tiprankstipranks
Trending News
More News >
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID

Compare Ovid Therapeutics (OVID) vs. Competitors

Compare
1,691 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ovid Therapeutics
$1.73
$126.76M
-3.38
90.32%
8 Buy
0 Hold
0 Sell
Strong Buy
Opus Genetics
$2.11
$145.51M
-1.16
37.93%
9 Buy
0 Hold
0 Sell
Strong Buy
Zentalis Pharmaceuticals
$1.41
$174.85M
-1.36
2.16%
4 Buy
2 Hold
0 Sell
Moderate Buy
Inhibikase Therapeutics
$1.67
$229.19M
-2.93
-46.13%
4 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$19.06
$171.17M
-0.87
48.79%
3 Buy
0 Hold
0 Sell
Strong Buy
Biomea Fusion
$1.33
$94.04M
-0.56
-68.62%
4 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OVID
Ovid Therapeutics
1.73
0.91
110.98%
IRD
Opus Genetics
2.00
0.58
40.85%
ZNTL
Zentalis Pharmaceuticals
2.84
0.09
3.27%
IKT
Inhibikase Therapeutics
1.67
-1.28
-43.39%
SRZN
Surrozen
19.06
7.91
70.94%
BMEA
Biomea Fusion
1.34
-2.64
-66.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts